This week's Fierce Biotech is brought to you by Cerba.

Complimentary Whitepaper Download

Hi E, check out this Fierce Whitepaper we think you'll like:

How cell and gene therapies are forcing sponsors to rethink safety and efficacy monitoring

In this insightful document, we dissect the transformative power of cell and gene therapies, particularly in cancer treatment. Patients once faced with limited lifespans now have access to options that significantly extend their lives. In this white paper, you’ll learn:

• How cell and gene therapies are upending drug development
• The role of assay development, logistics and flow cytometry
• What is needed to effectively support cell and gene therapy trials
• Real-world examples of safety and efficacy monitoring
• And more